Read on
GFBiochemicals made a forward integration step at the start of this year through its acquisition of Segetis. The levulinic acid manufacturer wants to operate closer to the market to incorporate specific derived chemicals in existing applications, such as detergents.
Editorial office / Italy

GFBiochemicals is a company of Italian origin, with a 1,200-tonne production facility in Caserta and plants at Brightlands Chemelot Campus and, since the takeover of Segetis, also in the USA (Minnesota). There is a small team in Geleen which includes R&D manager Rudy Parton. Together with several DSM colleagues, he came to GFBiochemicals in 2014.

‘The company worked on a direct route from C6 sugars to levulinic acid from 2008 to 2014. It used the Biofine process under licence for that purpose. But GFBiochemicals could not get this technology operational in Caserta. At the time we analysed the process in Caserta and made changes to the hardware and the process conditions and added new equipment. The major drawbacks were in the reactor technology and the purification of the levulinic acid.’

Read the full article.